HGSI Related Analyst PT Change
-
Leerink Swann Downgrades Human Genome Sciences (HGSI) to Market Perform; Limited Visibility
-
Collins Stewart Downgrades Human Genome Sciences (HGSI) to Neutral; Survey Suggests Lackluster 2012
-
RBC Capital Downgrades Human Genome Sciences (HGSI) to Sector Perform
Back to HGSI Stock Lookup
